the following (,ug/ml) : DL-ethionine, 1000; a-methyl-DL-methionine, 1000; DL-norleucine, 1000; thymine, 60; L-valine, 40; other amino acids, 20. GeneticaZ techniques. (i) Transduction. The technique of Smith (1961) was used. (ii) Conjugation. Overnight NB cultures of recipient and donor strains were mixed in the ratio I : I and the mixtures incubated without shaking for 30 min. Dilutions ( I O -~) were then made in NB with gentle mixing and 0 -2 ml portions of these spread on to appropriately supplemented MA plates. Identical plates were spread with recipient and donor strains separately as controls. All plates were incubated for 40 to 48 h. (iii) Episome transfer. Both transfer and curing of episomes were as described by Hobson & Smith (1973) .
Enzyme assays. Bacteria were cultured, extracts prepared and SAM synthetase activity assayed as described by Hobson & Smith (I 973). The N6N10-methylenetetrahydrofolate reductase assay was that used by Whitehouse & Smith (1973) . Growth experiments. Bacterial cultures were grown to stationary phase in appropriately supplemented MM, concentrated tenfold and diluted into 15 ml fresh MM supplemented as required to give an extinction of 0.05 to 0. I measured with a Unicam SP500 spectrophotometer (650 nm, I cm light path). These cultures were incubated in 25 ml conical flasks on a reciprocating shaker at 37 "C. Samples (1.5 ml) were removed at approximately hourly intervals, their extinction measured as before and the samples discarded. 
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Fig. I (c).
For legend see opposite.
RESULTS A N D D I S C U S S I O N
The norleucine resistance and ethionine sensitivity of cysJ538 thyA Nol-r was first confirmed by growth experiments in liquid medium. The mutant was similarly shown to be sensitive to a-methylmethionine so that the Nol-r mutation is unlikely to be of the metA(fbr) type or to affect the methionine-specific permease because mutants of the permease are resistant to this analogue (Ayling & Bridgeland, 1972) . It was possible that the mutation was in either the metJ or metK gene, both of which are involved in repression by methionine of its own synthesis, but gave a different analogue resistance pattern from previously studied mutations in these genes. MetJ is about 95 and 45 % cotransducible with the metB and metF structural genes respectively, and metK is about I % cotransducible with serA (Lawrence et al. 1968 ). However, in transduction crosses using cysJ538 thyA Nol-r as donor no linkage of Nol-r with any of these auxotrophic markers could be detected out of at least 300 transductants tested in crosses with metB and metF as recipients and at least 1000 transductants with serA as recipient, showing that Nol-r is not in either the metJ or metK gene. CysJ538 thyA Nol-r had the same SAM synthetase activity as wild-type and so oannot be defective in some subunit or cofactor of the metK enzyme.
In seeking a defect in methionine regulation, cysJ538 thyA Nol-r was shown not to excrete methionine in cross-feeding tests with a methionine auxotroph on supplemented MA (as in Lawrence et al. 1968) but other mutants do not excrete methionine and yet have elevated levels of methionine biosynthetic enzymes and methionine pools (Hobson, I 973) . However, the cysJ538 thyA Nol-r N6iVo-methylenetrahydrofolate reductase (involved in the terminal step of methonine biosynthesis) was found to be neither derepressed nor resistant to repression by LO mwi-methionine, and its methionine pool was the same as that of wild type as determined by a method involving a bioassay of methionine in cell extracts (Hobson, 1973) . Thus this Nol-r mutation, unlike all others which lead to norleucine resistance, does not affect methionine regulation.
Another explanation for the Nol-r phenotype could be interference with uptake of norleucine. This analogue is transported at low efficiency by the methionine permease (Ayling & 
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Short communication Bridgeland, I 972) and norleucine, leucine and isoleucine compete with valine for uptake by Escherichiu coli, suggesting common uptake systems for these compounds (Cohen & Rickenberg, 1956 ). In addition, if part of the inhibition of wild type by norleucine results from interference with synthesis or utilization of another amino acid besides methionine, the Nol-r mutation could cause overproduction of the relevant amino acid. For example, Trupin, Dickerman, Nirenberg & Weissbach (1966) showed that norleucine could be activated by tRNALe". To test these hypotheses, the reversal of norleucine inhibition of wild-type growth by growth concentrations of methionine, valine and leucine was tested in MM. All three amino acids stimulated growth, methionine having the largest effect, their combined effects almost completely reversing the inhibition (Fig. I a) . Thus norleucine must interfere with either uptake, synthesis or utilization of all three compounds. As expected, methionine did not stimulate growth of metK"p5 (a mutant which overproduces methionine) in norleucine, but valine and leucine increased growth as with wild type (Fig. ~b ) .
However, when the growth experiments were repeated with cysJ538 thyA Nol-r, valine had no stirnulatory effect on growth in norleucine while methionine and leucine retained their stimulation (Fig. I c) . Thus in this mutant the interference of norleucine with valine metabolism seems to be blocked. This could mean that cysJ538 thyA Nol-r lacks a valine uptake system, overproduces valine, or somehow affects the utilization of this amino acid, perhaps by altering the tRNA synthetase.
Knowledge of the genetic map location of the Nol-r mutation could help with interpretation of the nature of the defect it causes, e.g. if it mapped in the ilv (isoleucine/valine) cluster. Preliminary conjugation crosses were carried out using cysJ538 thyA Nol-r as a recipient and ~f r~2 Z e u and ~f r~3 h i s as donors with separate selection for cys+ and thy+. C y d and thyA map at about 90 and 92 min respectively (Sanderson, 1972) . With ~frszleu, whose origin is at about 55 min, 95 to IOO yo linkage of Nol-r to both markers was obtained.
The HfrK3hi.s origin is at about 93 min and transfer occurs with thyA as a very late marker.
With this Hfr strain few thy+ recombinants were obtained, but 30 yo linkage with Nol-r was found whereas linkage between cysJ and Nol-r was low (7%). These results suggest that Nol-r lies between cysJ and the ~f r~3 origin. This is in agreement with results obtained by transferring F'-factors to cysJ538 thyA Nol-r. Two episomes were used: K L F I~ which carries the region of the genome from metC at about 102 min to just beyond thyA but not extending into the cys cluster, and another F'-factor carrying the region from about 94 to 90 min, that is including the cys genes. Each episome was transferred with selection for thy+ and in each case the heterogenotes were found to be sensitive to norleucine. Curing of the episome resulted in the simultaneous appearance of norleucine resistance and a thymine requirement. Thus Nol-r is recessive and must map in the region covered by both episomes between the cys cluster and lysA (94 min). However, when phage grown on cysJ538 thyA Nol-r, or the cys+ or cys+thy+ derivatives, was used to transduce to prototrophy mutants in the cys cluster and also in thyA, urgB and lysA which are all cotransduced by phage Pz2, no norleucine-resistant transductants were obtained from at least 300 scored in each cross. Thus the most likely map position for the Nol-r mutation is between the two linkage groups, near recA (Sanderson, J 972).
In Escherichiu coli, mutants which over-produce valine map in the ilv cluster, in genes concerned with branched-chain amino acid synthetases or in uzl (azaleucine resistance), all of which map away from the postulated Nol-r location (Umbarger, 1971 ; Taylor & Trotter, 1972) . However, it is possible that the Nol-r mutation is in a different, previously unrecognized valine regulatory gene. Nol-r could possibly reduce incorporation of valine into protein, but
